How many insider declarations has New Enterprise Associates 17, L.P. filed?

New Enterprise Associates 17, L.P. has filed 4 public insider declarations with SEC (Form 4).

What is New Enterprise Associates 17, L.P.'s role?

New Enterprise Associates 17, L.P.'s reported role is not specified by the regulator across the filings.

Which companies does New Enterprise Associates 17, L.P. report trades for?

New Enterprise Associates 17, L.P. reports trades for 3 companies, including Monte Rosa Therapeutics, Inc..

What is New Enterprise Associates 17, L.P.'s declared buy vs sell volume?

Across the available history, declared buys total 939k€ and disposals 0.

← Executives ★ Sign in to follow

NE

New Enterprise Associates 17, L.P.

Other

US·SEC (Form 4)

Monte Rosa Therapeutics, Inc.Korro Bio, Inc.MBX Biosciences, Inc.

0

Total declarations

0

Companies

€938,602

▲ Purchases (1 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

1

Disclosed sells

0

T+90 hit rate

0%

T+90 mean return

-9.7%

Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Explore the full record of transactions filed by New Enterprise Associates 17, L.P.. Director active across 3 companies, notably Monte Rosa Therapeutics, Inc.. In total, 4 reports have been recorded. Split: 1 buy · 0 sell. Total volume traded: €939k. Activity tracked since 22 April 2024. The latest transaction was filed on 22 April 2024 (Acquisition). Regulator: SEC (Form 4). All data is free.

Declarations4 total

●

New Enterprise Associates 17, L.P.

Executives16 Sept 2024MBX Biosciences, Inc.

13SEC ↗

1,023,103 sharesCommon StockSEC:0000950170-24-107537:0

▲

New Enterprise Associates 17, L.P.

Executives22 Apr 2024Korro Bio, Inc.

$999,99243SEC ↗

17,857 shares@ US$56.00100.0% of flowCommon StockSEC:0000950170-24-047686:0